Vaccine Development (Industry News)

Company Reports Promising Results on Universal Vaccine Immune Stimulant

Published in Vaccine Weekly, February 9th, 2000

Epimmune Inc. announced the publication of data in The Journal of Immunology showing that constructs composed of Padre^TM, together with carbohydrate antigens, are potent immunogens that elicit strong antibody responses specific to the target antigen.

The Company believes these data provide further support that Padre could prove important in improving vaccines against a number of infectious diseases and cancers.

Carbohydrate antigens are important vaccine targets for a number of infectious diseases including bacteria that cause pneumonia and meningitis as well as many cancers including breast, colon, lung, prostate, and melanoma. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-02-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry